Daniel Rodgers’s full response to The Oregonian/OregonLive’s Portland school board candidate questionnaire
Today 8:05 AM
Dan Rodgers is seeking the Zone 5 seat on the Portland school board representing the district’s Northeast neighborhoods.Photo courtesy of Dan Rodgers
Facebook Share
Daniel Rodgers, a family physician, is running for the Portland school board seat representing much of Northeast Portland that is being vacated by one-term incumbent Scott Bailey. He says viewing the impact of school closures on his young patients, particularly those with disabilities, is part of what drove him to step up to run.
He is one of two candidates for the Zone 5 seat, along with small business owner Gary Hollands.
BBC News
Published
image copyrightGetty Images
US health regulators have lifted an 11-day pause on the Johnson & Johnson (J&J) Covid-19 jab, but will add a warning label about the potential for extremely rare blood clots.
A Centers for Disease Control and Prevention (CDC) panel earlier approved restarting US rollout of the shot.
Fifteen vaccine recipients suffered from a dangerous blood clot out of nearly eight million given the jab.
This week, Europe s drug regulator also ended restrictions on the J&J vaccine.
European regulators this month also linked similar, highly unusual blood clots to the AstraZeneca Covid-19 shot, but found the benefits of the drug outweighed any risks.
US Ends Pause On Johnson & Johnson Vaccine, Says More Benefits Than Risks ndtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ndtv.com Daily Mail and Mail on Sunday newspapers.
Apr 23, 2021 / 09:15 PM EST
(CNN) The U.S. Centers for Disease Control and Prevention and Food and Drug Administration lifted their recommended pause on use of Johnson & Johnson’s coronavirus vaccine Friday and said the label will be updated to warn of blood clot risks.
Vaccinations could resume as soon as Saturday, the FDA said.
The agencies acted quickly after a vote by the CDC’s Advisory Committee for Immunization Practices recommended lifting the pause.
“We have concluded that the known and potential benefits of the Janssen COVID-19 vaccine outweigh its known and potential risks in individuals 18 years of age and older,” acting FDA Commissioner Dr. Janet Woodcock said in a statement.